warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
LCCC1317: GENIC, A Genotype-Directed Phase II Study of Irinotecan Dosing in Metastatic Colorectal Cancer (mCRC) Patients Receiving FOLFIRI + Bevacizumab
Brief Description  
Estimate PFS in previously untreated mCRC patients receiving FOLFIRI + bevacizumab when irinotecan dose is based on UGT1A1 genotype
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Rectum
Status  
OPEN
Start Date  
03/04/2015
IRB Number  
00010715
Principal Investigator  
Patel, Jai Narendra
Contact Name  
April Brown

For More Information, Contact  April  , Brown
Phone:  704-403-3536 Fax:    
Email:  April.Brown@carolinashealthcare.org
Address:100 Medical Park Drive Suite 110 Concord, 28025
Close